Shenzhen Oriental Fortune Capital
Tier 3 Industrial
Bio
Shenzhen Oriental Fortune Capital Shenzhen Oriental Fortune Capital is a major Chinese VC managing ¥20B+ (RMB) since 2006, with a portfolio of 500+ companies and 100+ IPO exits. The fund focuses on healthcare, biopharma, medical devices, and life sciences while also being active in hard tech sectors including semiconductors, advanced manufacturing, and new materials. Government-backed with deep connections to the Shenzhen ecosystem. China's hardware and manufacturing capital. Oriental Fortune
Industries
BiotechMedTechAI Infrastructure
Stages
Series ASeries B+
Geography
China
Notable investments
- Fosun Pharma
- Walvax Biotechnology